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Evolvability—the capacity to generate beneficial her-
itable variation—is a central property of biological
systems. However, its origins and modulation by
environmental factors have not been examined sys-
tematically. Here, we analyze the fitness effects of
all single mutations in TEM-1 b-lactamase (4,997 var-
iants) under selection for the wild-type function
(ampicillin resistance) and for a new function (cefo-
taxime resistance). Tolerance to mutation in this
enzyme is bimodal and dependent on the strength
of purifying selection in vivo, a result that derives
from a steep non-linear ampicillin-dependent rela-
tionship between biochemical activity and fitness.
Interestingly, cefotaxime resistance emerges from
mutations that are neutral at low levels of ampicillin
but deleterious at high levels; thus the capacity to
evolve new function also depends on the strength
of selection. The key property controlling evolvability
is an excess of enzymatic activity relative to the
strength of selection, suggesting that fluctuating en-
vironments might select for high-activity enzymes.
INTRODUCTION
Biological systems are often regarded as remarkably tolerant
of genetic perturbations. Mutational robustness has been
observed at nearly all levels of biological organization, from pro-
tein structure and function (McLaughlin et al., 2012; Rennell
et al., 1991; Suckow et al., 1996) to metabolic flux (Kacser and
Burns, 1981) to regulation of gene expression (Wagner, 2005a)
to development (Waddington, 1942, 1953). Because processes
that buffer the effects of genetic variation inevitably have conse-
quences for evolutionary outcomes, an understanding of both
the causes and consequences of robustness is of central impor-
tance to biology (de Visser et al., 2003; Masel and Siegal, 2009;
Wagner, 2005a). For example, recent studies (Draghi et al., 2010;
Hayden et al., 2011; Payne and Wagner, 2014; Wagner, 2008)
show that robustness can facilitate the adaptation of biological
systems to environmental change—a property sometimes called
‘‘evolvability’’ (Kirschner and Gerhart, 1998). Besides being
essential to basic evolutionary theory, understanding robustness882 Cell 160, 882–892, February 26, 2015 ª2015 Elsevier Inc.may also be important in the engineering of useful proteins that
are more resilient to the effects of random mutations and for un-
derstanding the emergence of mutations that impact human
health.
Due to their importance in defining phenotypes at the cellular
and organismal level, and the ease with which large numbers
of mutations can be introduced and assessed, proteins repre-
sent ideal model systems for studying robustness and evolvabil-
ity. The tolerance of many proteins to mutations has been as-
sessed in a number of important studies with high-throughput
site-directed and random mutagenesis (Fowler et al., 2010;
Guo et al., 2004; Huang et al., 1996; Jacquier et al., 2013;
Loeb et al., 1989; McLaughlin et al., 2012; Melnikov et al.,
2014; Rennell et al., 1991; Suckow et al., 1996). Overall, these
studies suggest that the function of proteins is insensitive to
the vast majority of amino acid changes (Bowie et al., 1990). By
contrast, it is generally accepted that many missense mutations
have measurable biophysical effects (e.g., on protein stability),
supporting a view that most mutations are not neutral at the
biochemical level (DePristo et al., 2005; Tokuriki and Tawfik,
2009). One possible explanation for this discrepancy is that
robustness and evolvability are characteristics that ultimately
refer to organismal fitness, a property that is difficult to assess
and whose relationship to biochemical parameters of a protein
could be complex and is generally unknown. Indeed, many
comprehensive studies of mutational tolerance in proteins have
assessed biochemical traits (e.g., protein-binding affinity; Fowler
et al., 2010; McLaughlin et al., 2012) or other phenotypes (e.g.,
minimal inhibitory concentration of antibiotic, MIC; Firnberg
et al., 2014; Jacquier et al., 2013); although much has been
learned from these studies, the relationships between these
properties and fitness are less clear.
More fundamentally, it is logical that the relationship between
organismal fitness and biochemical parametersmight vary signif-
icantly with the strength of selective pressure acting on the pro-
tein. If so, then robustnessandevolvabilitymustnotbeconsidered
as absolute, invariant features of proteins but instead as proper-
ties that depend on environmental or experimental conditions
that control purifyingselection. Toexamine these ideas rigorously,
we require (1) a quantitative mapping of the relationship between
in vivo fitness and in vitro biochemistry in an appropriate model
system, (2) a study of how both mutational sensitivity to existing
function and the capacity to evolve new function dependupon se-
lection pressure, and (3) a mechanistic principle for how these
characteristics emerge from the properties of extant proteins.
Figure 1. Experimental Scheme
(A) Strategy for comprehensive assessment of the
fitness effects of mutations in TEM-1 (Experi-
mental Procedures and Extended Experimental
Procedures). Each codon corresponding to the
263 amino acid positions of the mature TEM-1
protein was individually mutated to NNS (where N
is a mixture of all four nucleotide bases, and S a
mixture of C and G) using PCR. PCR products
were combined in equimolar ratios, cloned into the
pBR322 plasmid, and transformed into E. coli. The
resulting whole-gene saturation mutagenesis li-
brary was then selected in ampicillin at either
0 mg/ml (unselected library) or various concentra-
tions (selected library). Illumina 75 bp paired-end
sequencing was used to obtain allele counts N for
each amino acid mutation a at every position i and under each selection condition; relative fitness effect Fai is assessed as the logarithmic increase in allele counts
in the selected library versus the unselected library, relative to the wild-type allele.
(B) Results of growth assays (n = 3) for E. coli cells harboring wild-type TEM-1 under selection at various concentrations of ampicillin, indicating that growth is
unaffected at ampicillin concentrations% 2,500 mg/ml (Extended Experimental Procedures).
See also Figure S1.The problem of how robustness and evolvability are condi-
tional on selection strength can be investigated in proteins
conferring antibiotic resistance by comprehensive experi-
mental assessment of the fitness effects of mutations as a
function of antibiotic concentration. Here, we focus on a
powerful model system for protein evolution studies, TEM-1
b-lactamase (Bershtein et al., 2006; Salverda et al., 2010;
Weinreich et al., 2006). TEM-1 is an enzyme that hydrolyzes
penicillin-class b-lactam antibiotics (e.g., ampicillin); the ability
of bacteria to survive and reproduce (i.e., fitness) in the pres-
ence of these antibiotics relies solely on TEM-1 activity (Mat-
agne et al., 1998; Medeiros, 1997). Using an application of
deep sequencing (Fowler et al., 2010; McLaughlin et al.,
2012), we determined the effects on organismal fitness of all
single amino acid mutations in TEM-1 (4,997 mutations) under
selection for ampicillin resistance (the wild-type function) and
for resistance to cefotaxime (a new function). By assessing
fitness under increasing concentration of ampicillin, we
demonstrate that robustness indeed depends strongly and
inversely on the strength of purifying selection. The pattern
of mutational sensitivity is hierarchically organized in the
atomic structure, building out from the active site as a function
of ampicillin concentration in physically contiguous but aniso-
tropic amino acid networks. Furthermore, we find that in TEM-
1, evolvability is facilitated by robustness and therefore is also
dependent on the strength of selection; mutations conferring
cefotaxime resistance are predominantly neutral under selec-
tion at low to moderate ampicillin concentrations yet delete-
rious to fitness under high concentration. To mechanistically
understand these properties, we propose a simple kinetic
model that describes the fitness effects of all mutations in
our study as a function of ampicillin concentration and intra-
cellular b-lactamase activity. This model shows that, mecha-
nistically, robustness and evolvability can be understood to
arise from an excess of intracellular enzymatic activity relative
to the strength of selection, a finding that suggests a role for
fluctuating environments in the evolution of high-activity
enzymes.RESULTS
Whole-Gene Saturation Mutagenesis and Fitness under
Ampicillin Selection
Weused site-directedmutagenesis to create awhole-gene satu-
ration mutagenesis library comprising all 19 possible single-site
amino acid point mutations at every position in the mature form
of TEM-1 b-lactamase (4,997 amino acid mutations total; Exper-
imental Procedures and Extended Experimental Procedures;
Figure 1A). To assess the effects of selection strength on robust-
ness, the library was transformed into E. coli and selected at
several concentrations of ampicillin ranging from zero to a
concentration just below that at which cells encoding even
wild-type TEM-1 decline considerably in fitness (2500 mg/ml
ampicillin; Extended Experimental Procedures; Figure 1B).
Illumina 75 bp paired-end sequencing was used to obtain
counts for each mutant allele after selection at each ampicillin
concentration; an average of 1,000 counts per amino acid muta-
tion was obtained under conditions of no selection (0 mg/ml
ampicillin; Figure S1A). The relative fitness Fai of each amino
acid mutation a at each position i is assessed as the logarithm
of the allele counts in the selected population (Na;seli ) versus the
unselected population (0 mg/ml ampicillin, Na;unseli ), relative to
the wild-type allele:
Fai = log10
"
Na;seli
Na;unseli
#
 log10
"
Nwt;seli
Nwt;unseli
#
: (1)
Mutations that show no fitness effect have values of Fai close to
that ofwild-type (Fai z0), and thosewith an increaseordecrease in
fitness relative towild-type have a positive or negative value of Fai ,
respectively, in proportion to their effect. The values of Fai are
generally reproducible over two independent trials (r2 = 0.91 at
2500 mg/ml ampicillin; Figure S1B), and effects due to codon
biasunderampicillin selectionappear tobesmall (r2=0.96 for rela-
tive fitness between all synonymous mutations at 2500 mg/ml
ampicillin; Figure S1C). Examination of the distribution of Fai for
all mutations under no selection (0 mg/ml ampicillin) provides aCell 160, 882–892, February 26, 2015 ª2015 Elsevier Inc. 883
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Figure 3. Distribution of Fitness Effects
(A–E) Histograms of Fai values show that the dis-
tribution of the fitness effects (DFE) is bimodal and
depends on the strength of purifying selection: (A)
10, (B) 39, (C) 156, (D) 625, and (E) 2,500 mg/ml
ampicillin. Red lines are heuristic fits to a bi-
Gaussian function. The range of Fai that corre-
sponds to a statistically neutral fitness effect is
indicated in gray. Insets show DFEs enlarged over
the range 0–0.1.
(F and G) The pattern of mutational sensitivity
involves spatially heterogeneous yet physically
connected networks of residues, building out from
the active site and core as the strength of purifying
selection is increased. Shown are (F) surface and
(G) slice representations of the pattern of sensi-
tivity to single-site amino acid point mutations at
each ampicillin concentration mapped onto the
structure of TEM-1 (PDB: 1FQG). Colored spheres
indicate residues with a significant positional
fitness effect (see Figure S2); different colors
indicate results at each ampicillin concentration.
Co-crystallized b-lactam (penicillin G) is shown
as yellow stick bonds. See also Figure S2 and
Table S2.basis for defining cutoffs for Fai corresponding to statistically
neutral effects on fitness (mean ± two SD in Fai ; Figure S1D).
Robustness Is Conditional on the Strength of Purifying
Selection
Figure 2 shows the fitness effect of all single amino acid
mutations in TEM-1 at all ampicillin concentrations examined
(10, 39, 156, 625, and 2500 mg/ml; see also Table S1). Under
weak selection at a low ampicillin concentration (39 mg/ml; no se-
lection was observed at 10 mg/ml; Figures 2A and 3A), the vast
majority of mutations are statistically neutral (Fai z0), and only
a small fraction of mutations significantly affect fitness (Figures
2B and 3B). These include highly conserved positions within
the active site (S70, K73, S130, D131, N132, K234, and G236;
numbering according to Ambler; Ambler et al., 1991) but also aFigure 2. Fitness Effects of All Single Amino Acid Mutations in TEM-1 under Increasing Ampic
Shown are the datamatrices containing the relative fitness effect for every amino acidmutation at every positio
(B) 39, (C) 156, (D) 625, or (E) 2,500 mg/ml. Rowswithin eachmatrix depict positions along the primary sequenc
of the 20 amino acids (in alphabetical order by one-letter code indicated at bottom of A). Relative fitness effect
deleterious fitness effect, red a positive fitness effect, and white no fitness effect relative to wild-type. Posi
ampicillin are colored gray. The secondary structure of the wild-type sequence is indicated to left of (A). Se
(S70-X-X-K73, S130-D131-N132, E166, and K234-S235-G236) are indicated to the right of (E). See also Tab
Cell 160, 882–892,subset of more moderately conserved
positions distributed within the protein
core (Figures 3F and 3G). As the ampi-
cillin concentration used for selection is
further increased, the overall fitness cost
of mutations dramatically increases—
both in the number of mutations that
show a fitness effect and in the degree
of their effect relative to wild-type (Fig-
ures 2C–2E and 3C–3E). To some extent,these results seem obvious; it is reasonable to expect that the
fitness cost of mutations in an enzyme will depend on the
strength of purifying selection for its function. In contrast, no sin-
gle mutations at any concentration significantly increase fitness,
indicating that TEM-1 occupies a local peak in its genotype-
fitness landscape under the conditions of these experiments.
More interestingly, the distribution of the fitness effects of mu-
tations (DFE) is decidedly bimodal, with one mode correspond-
ing to mutations with significant deleterious effects on fitness,
and the other mode comprising those with neutral or nearly
neutral fitness effects (Figures 3A–3E and Table S2). The
strength of ampicillin selection controls the fraction of mutations
in these two modes; increasing antibiotic concentration causes
the relative proportion of mutations in the mode with deleterious
mutations to increase and in themodewith neutral/nearly neutralillin Selection
n in TEM-1 under selection with ampicillin at (A) 10,
e of TEM-1, and columns indicate amutation to one
is depicted colorimetrically with blue representing a
tions for which no data were obtained at 10 mg/ml
veral highly conserved motifs within the active site
le S1.
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Figure 4. A Phenotype-Fitness Landscape
for TEM-1
(A) Overview of the kinetic model describing
fitness as a function of ampicillin concentration
and intracellular b-lactamase activity (Experi-
mental Procedures and Extended Experimental
Procedures). The periplasmic concentration of
ampicillin (green) is determined by the rate of
passive diffusion across the outer membrane and
the rate of inactivation (hydrolysis, denoted by X)
by b-lactamase (red). Growth (i.e., fitness) is pro-
portional to the rate of peptidoglycan strand-
joining (yellow) by PBPs (orange); PBP activity,
and thus fitness, is inhibited (dashed line) by un-
hydrolyzed ampicillin in the periplasm.
(B–E) Surface representation of the model
revealing a non-linear relationship between
phenotype (intracellular b-lactamase activity: Km
and Vmax) and fitness marked by a plateau at
neutrality (Fai z0) that is dependent on the strength
of selection: (B) 39, (C) 156, (D) 625, and (E)
2,500 mg/ml ampicillin. Model estimated values of
kinetic parameters and fitness for wild-type TEM-1
(green sphere) and all 4,997 single mutations (sil-
ver spheres) are shown.
See also Figure S3 and Table S3.mutations to decrease. In addition, to different extents, both
modes shift toward a greater average fitness cost as a function
of ampicillin concentration (Table S2). Thus, these data (Figures
2 and 3) reveal that robustness in TEM-1 is strongly dependent
on the strength of selection—under weak selection, TEM-1 is
more robust as most mutations are neutral or nearly neutral in
their fitness effects. But as selection is increased, robustness
concomitantly decreases as more and more mutations become
deleterious to fitness.
Mapping of the data onto an atomic structure of TEM-1 reveals
a spatially anisotropic pattern of amino acid contributions to
organismal fitness (Figures 3F and 3G). Here, we describe the
average fitness cost of all mutations at each position ðhFai iaÞ at
each ampicillin concentration; for comparison, positions sensi-
tive to mutation are defined based on the distribution of hFai ia un-
der selection at 2500 mg/ml ampicillin (Figure S2). Under weak886 Cell 160, 882–892, February 26, 2015 ª2015 Elsevier Inc.selection (39 mg/ml ampicillin), mutation-
sensitive positions comprise a physically
contiguous but anisotropic network of
residues buried within the protein core
and extending out from the active site.
As the level of selective pressure is
increased, this main ‘‘functional core’’ ac-
quires successive shells of mutation-sen-
sitive residues that grow outward until
nearly the whole protein core shows
some degree of fitness cost upon muta-
tion. Nevertheless, the heterogeneity in
positional contribution to fitness persists
even at the highest levels of ampicillin;
the most mutationally sensitive positions
at 2500 mg/ml ampicillin are similar tothe functional core defined at 39 mg/ml ampicillin (Figure 7,
compare panels D and F).
Robustness as an Excess of Intracellular Enzymatic
Activity Relative to the Strength of Purifying Selection
To study the mechanistic basis for both the dependency of
robustness on selection strength and the bimodality of the
DFE, we developed a simple kinetic model describing relative
fitness as a function of ampicillin concentration and intracellular
b-lactamase activity (Figure 4A, Experimental Procedures, and
Extended Experimental Procedures). In this model, organismal
fitness is proportional to the flux of peptidoglycan substrate
through DD-carboxypeptidases and other penicillin-binding pro-
teins (PBPs) involved in cell-wall biogenesis, with ampicillin
acting as a competitive inhibitor of this process. The periplasmic
concentration of ampicillin is dynamically set by the balance of
intracellular b-lactamase activity and passive diffusion of ampi-
cillin across the outer membrane (Zimmermann and Rosselet,
1977). We determined values for the free parameters of our
model by globally fitting the experimental data obtained for all
4,997 mutations (Extended Experimental Procedures and Table
S3). The free parameters uniquely converge, and the model fits
the data well with an overall r2 = 0.98.
The main result of our model is the finding of a non-linear
phenotype-fitness relationship in which fitness saturates at
different levels of enzyme activity as a function of the concentra-
tion of applied ampicillin (Figures 4B–4E). The non-linearity
arises from two sources: the steady state achieved between
diffusion and hydrolysis of ampicillin and the competitive inhibi-
tion of the PBPs. This result provides a simple explanation for
both the dependence of mutational robustness on selection
strength and the bimodal nature of the DFE. In the model,
enzyme activity of every mutant is defined by two parameters,
the maximum intracellular rate of ampicillin hydrolysis (Vmax)
and the concentration of ampicillin that produces half-maximal
rate (Km). Due to the high overall activity of TEM-1 for ampicillin,
the wild-type enzyme resides well within the saturated regime
(plateau) of the fitness-activity relationship. Mutational robust-
ness emerges as a consequence because within the saturated
region, changes in enzyme activity due to mutation have negli-
gible effects on fitness (de Visser et al., 2003; Hartl et al., 1985;
Kacser and Burns, 1981; Wagner, 2005a). The model is also
consistent with the dependence of robustness on the strength
of selection because fitness saturates at increasingly higher
levels of activity as the ampicillin concentration increases (Fig-
ures 4B–4E, S3A, and S3B). That is, robustness collapses
steadily with increasing selection pressure because the fitness-
activity relationship depends on the steady-state levels of ampi-
cillin in the periplasm. Finally, the bimodal nature of the fitness ef-
fects ofmutations can be understood as a direct consequence of
the steep non-linearity relating enzyme activity to fitness. For
example, mutational variation in enzyme activity has basically
two outcomes: to stay in front of the non-linearity and have a
relatively negligible effect on fitness, or to cross the non-linearity
‘‘threshold’’ and display a profound effect on fitness (see Figures
S3C–S3G for a simulation). Further contribution could come from
inherent non-linearities in the effects of mutations on TEM-1 ac-
tivity, but the model shows that such is not required for bimo-
dality in the DFE. In short, the model shows that robustness
and its dependency on the strength of selection arise from the
high intracellular activity of TEM-1 and the ampicillin-dependent
non-linear saturation relationship between enzyme activity and
fitness.
A general model for mutational robustness in proteins has
been previously proposed based on the thermodynamic stability
of proteins. The idea is that the ‘‘extra’’ stability beyond that
required to asymptotically populate the native state provides a
thermodynamic basis for robustness by buffering the slightly de-
stabilizing effects of most mutations (Bloom et al., 2005; Tokuriki
and Tawfik, 2009; Wylie and Shakhnovich, 2011). We note that
our conclusions are not inconsistent with this view; the overall
rate of ampicillin hydrolysis in vivo is a combination of both the
fraction of natively folded b-lactamase protein and the specific
activity of the native state, and mutations could influence eitheror both properties. More generally, we propose that robustness
comes from an excess of intracellular enzymatic activity relative
to the fitness threshold present at a particular strength of selec-
tion—a description that combines the probability of native-state
folding with the biochemical parameters controlling catalytic
power and accounts for the dependency of robustness on the
strength of selection.
Evolvability and Fitness under Cefotaxime Selection
Robustness implies invariance of organismal fitness upon muta-
tion, which at first glance suggests that robust biological systems
should have a decreased ability to evolve new phenotypes, or
decreased evolvability. On the other hand, mutations that are
neutral with regard to the current or wild-type function might be
able to promote new functions; indeed, such ‘‘conditional
neutrality,’’ whether with respect to genetic background or envi-
ronmental factors, has been suggested to facilitate evolvability
by permitting the accumulation of mutations that could be useful
uponchanges in selective pressure (deVisser et al., 2003; Kirsch-
ner and Gerhart, 1998, 2005; Masel and Trotter, 2010; Wagner,
2005a, b). To assess the relationship between robustness and
evolvability in TEM-1, we performed selection on our whole-
gene saturationmutagenesis library in the presence of a different
b-lactam drug, cefotaxime. Cefotaxime is a poor substrate for
TEM-1, with an approximately 1000-fold decrease in kcat/Km for
cefotaxime versus ampicillin (z104 versus z107 M1s1,
respectively). As such, TEM-1 imparts no significant fitness
advantage; theminimal inhibitory concentration (MIC) of cefotax-
ime for E. coli cells encoding wild-type TEM-1 is essentially un-
changed from that of cells without b-lactamase (0.0625 mg/ml)
(Hall, 2002). However, single amino acid changes in TEM-1 are
known to increase resistance to cefotaxime both in nature and
in the laboratory (Matagne et al., 1998; Salverda et al., 2010). Se-
lection was performed at 0.15 mg/ml cefotaxime (approximately
double theMIC for TEM-1), and the fitness of eachmutation rela-
tive to wild-type TEM-1 determined as described above.
Figure 5 shows the fitness effect of all single mutations under
cefotaxime selection, and Figure S4 shows the corresponding
DFE (see also Table S4). In contrast to the results obtained under
ampicillin selection, no mutations show a significant fitness
decrease relative to wild-type TEM-1, a result that simply reflects
the already poor activity of TEM-1 on cefotaxime. However, a
small number of mutations (106 total, or 2%) act to increase
fitness; among these we observe alleles previously reported to
impart an extended-spectrum phenotype in both TEM-1 and/or
its homolog SHV-1 in clinical isolates (E104K, R164H, R164S,
D179G, D179N, G238A, G238S) (Matagne et al., 1998; Salverda
et al., 2010) and error-prone PCR libraries (Bershtein and Tawfik,
2008; Schenk et al., 2012).
Robustness and Adaptation in TEM-1
A comparison of the relative fitness effects obtained for each
mutation at each ampicillin concentration versus their respective
effects under cefotaxime selection reveals how the robustness
of TEM-1 under ampicillin selection (the current or wild-type
function) relates to its evolvability toward cefotaxime resistance
(a new function) (Figures 6A–6D). Under weak selection for ampi-
cillin resistance (e.g., 39 mg/ml ampicillin, Figure 6A), nearly allCell 160, 882–892, February 26, 2015 ª2015 Elsevier Inc. 887
Figure 5. Fitness Effects of All Single Amino Acid Mutations in
TEM-1 under Cefotaxime Selection
Shown is the data matrix depicting Fai for each amino acid mutation at each
position in TEM-1 under selection with the non-optimal TEM-1 substrate
cefotaxime at 0.15 mg/ml. Labels and coloring are as in Figure 2. Several po-
sitions previously reported to confer increased cefotaxime resistance upon
mutation in TEM-1 or its homolog SHV-1 are indicated at right (E104, R164,
D179, and G238). See also Figure S4 and Table S4.
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tistically neutral in their fitness effect in ampicillin; this includes
all the above-stated mutations found in clinical isolates. These
mutations are said to be conditionally neutral with respect to
the environment (as their phenotypes depend on the condition
of selection) and have been linked to the rate of evolution of
new phenotypes (Draghi et al., 2011; Wagner, 2005b). However,
under selection at increasing ampicillin concentration, mutations
conferring cefotaxime resistance have progressively deleterious
fitness effects in ampicillin; for example, the mutations R164H,
R164S, D179G, D179N, and G238S, which are neutral at
39 mg/ml ampicillin, now have significant deleterious fitness ef-
fects at 2,500 mg/ml ampicillin (Figure 6D). That is, the neutrality
of these mutations is itself conditional on the strength of selec-
tion, present at low levels of ampicillin and diminishing at higher
levels. Thus, for TEM-1, more useful genetic variation (mutations
conferring cefotaxime resistance) is proportionately available
when robustness is high (weak ampicillin selection) than when
robustness is low (strong ampicillin selection; Figure 6E).
To test this in an independent experiment, we created a library
of TEM-1 variants by error-prone PCR (average of 1 ± 1 muta-
tions per gene, Extended Experimental Procedures), trans-
formed into E. coli, and screened for growth of the population
on cefotaxime (0.2 mg/ml) either with prior selection (Figures
6F, S5A, and S5B) or with co-selection (Figures S5C and S5D)
on varying doses of ampicillin (Extended Experimental Proce-
dures). The data show that in fact, the growth of the population
of TEM-1 variants on cefotaxime is a function of ampicillin expo-
sure and very nearly reflects the fraction of mutations that confer
cefotaxime resistance but are statistically neutral for ampicillin in
the comprehensive single-mutation library (Figure 6E). We
conclude that in TEM-1, robustness enhances evolvability by
permitting environmentally conditional neutral mutations that
can confer cefotaxime resistance.
The Spatial Distribution of Cefotaxime Adaptation
in TEM-1
Mutations conferring initial cefotaxime resistance are distributed
broadly throughout the tertiary structure of TEM-1 and include
residues both in the core and on the surface of the protein (resi-
dues in dark gray, Figure 7). However, there is an interesting
and physically informative pattern to the organization of these
mutations. Few cefotaxime-adaptivemutations are directlywithin
the functional core defined by residues with significant fitness ef-
fects at 39 mg/ml ampicillin (residues in red, Figures 3G, 7A, and
7D), consistent with the finding that they are largely neutral in
fitness effect under weak ampicillin selection (Figure 6A). But
remarkably, the mutations conferring cefotaxime resistance are
organized into sparse, physically connected networks of amino
acids that connect a subset of surface positions to the functional
Figure 6. Robustness and Evolvability of
TEM-1
(A–D) Comparison of Fai values for all mutations
under ampicillin (x axis) versus cefotaxime selec-
tion (0.15 mg/ml; y axis) shows that most mutations
conferring significant cefotaxime resistance are
statistically neutral in fitness effect at a low ampi-
cillin concentration but deleterious at the highest
ampicillin concentration. Mutations that confer
cefotaxime resistance and are either statistically
neutral (ctxposampneut) or deleterious (ctxposampdel)
in fitness effect under selection at the indicated
ampicillin concentration are colored red and green,
respectively: (A) 39, (B) 156, (C) 625, and (D)
2,500 mg/ml ampicillin. Several mutations previ-
ously reported to impart an ‘‘extended-spectrum’’
phenotype in both TEM-1 and/or its homolog SHV-
1 in clinical isolates are indicated.
(E) A comparison of the fraction of statistically
neutral mutations that confer cefotaxime resis-
tance at each ampicillin concentration as deter-
mined from the whole-gene saturation mutagen-
esis data. Results are shown as the mean and SD
from two independent ampicillin selection experi-
ments for all mutations (orange) or those obtain-
able by single-nucleotide mutation from TEM-1
(blue).
(F) Results of growth experiments (n = 6) in which
an error-prone PCR library of TEM-1 was sub-
jected to pre-selection at several concentrations
of ampicillin followed by cefotaxime selection
(Extended Experimental Procedures). In (E) and (F),
asterisks denote that results at 2,500 mg/ml ampi-
cillin are significantly different from those at all
other ampicillin concentrations (one-way ANOVA
and post-hoc Tukey test, p < 0.05).
See also Figure S5.core (Figure 7D). The physical interpretation of such ‘‘pathways’’
of amino acid connectivity remain to be established but suggest
the possibility that these represent anisotropic collective modes
in the protein structure that functionally connect a small set of sur-
face sites to the protein active site (Lee et al., 2008; Reynolds
et al., 2011). This architecture makes it so that about 50% of
cefotaxime-adaptive single mutations (53/106 total) occur at sur-
face positions far from the active site. The effect of selection un-
der high levels of ampicillin is to reduce the set of mutations avail-
able for conferring cefotaxime resistance by reducing the
likelihood of those that occur within the protein core and near
to the active site (Figures 6D,7B, 7C, 7E, and 7F). Nevertheless,
the distributed architecture of adaptive mutations is such thatCell 160, 882–892,some surface positions (e.g., E104, T195,
E197, E240) still maintain the capacity for
initiation of cefotaxime resistancewhile re-
maining neutral over the full range of ampi-
cillin concentrations examined here.
DISCUSSION
In summary, these results show that both
the robustness and evolvability of TEM-1are not invariant properties of the protein but instead are depen-
dent on the strength of purifying selective pressure applied. At
low doses of ampicillin, the high activity of TEM-1 and the non-
linear dependence of fitness on enzyme activity rendermanymu-
tations statistically neutral in their fitness effects under moderate
selection conditions. Under these conditions, we find that the
constraints on fitness are loaded in a small, physically connected
network of residues in the TEM-1 tertiary structure—a functional
core—that is built around and extending from the active site.
Interestingly, a small fraction of positions showing neutral varia-
tion display the capacity to confer increased resistance to a
new b-lactam drug, cefotaxime, upon single amino acid muta-
tion. These positions comprise contiguous amino acid networksFebruary 26, 2015 ª2015 Elsevier Inc. 889
Figure 7. Structural Relationship of Robustness and Evolvability
(A–C) Shown are histograms of the average fitness effects of mutations at each position hFai ia under selection at (A) 39 mg/ml and (B and C) 2,500 mg/ml ampicillin
(see Figure S2). Red lines are fits to a double Gaussian function. The dashed line indicates a hFai ia cutoff for positions with significant mutational sensitivity (see
Figure S2), whereas colored bars indicate the range of hFai ia for positions shown on structures in panels to the right (note the lower range in C).
(D–F) The spatial pattern of adaptability toward cefotaxime (dark gray spheres) in the context of mutational sensitivity under ampicillin selection at (D) 39 mg/ml
(red spheres) or (E and F) 2,500 mg/ml (blue or white/blue spheres); shown are slices through the core of the TEM-1 protein, and the surface of TEM-1 is in mesh.
The number of adaptive mutations per position is in parentheses (note that not all positions conferring cefotaxime resistance are labeled). The data show that
adaptation to cefotaxime resistance in TEM-1 arises from different physically contiguous networks of residues that connect specific distal sites to the core
catalytic and structural residues defined by mutational sensitivity at low levels of ampicillin selection (red, D). At high levels of ampicillin (B and E), most core
positions display a significant fitness cost uponmutation, reducing the number of cefotaxime-adaptive but ampicillin-neutral mutations. The pattern of mutational
sensitivity remains heterogeneous even at high ampicillin levels (C and F), with positions showing the largest fitness cost similar to those with a significant fitness
cost at low ampicillin (compare D and F).that extend from the functional core to connect the active site to a
number of distantly positioned surface positions at which cefo-
taxime resistance can be acquired. The robustness of TEM-1,
however, collapses at high levels of ampicillin, as more and
more mutations are drawn into the regime where they affect
organismal fitness. With the loss of robustness, the capacity for
adaptation to cefotaxime is alsomuch reduced asmany adaptive
mutations that were neutral at low ampicillin concentration now
have a significant impact on fitness. It is important to note that
these data address only the initial single mutation step toward890 Cell 160, 882–892, February 26, 2015 ª2015 Elsevier Inc.the evolution of new function and with only two substrates; it
will be interesting to examine how paths of higher-order muta-
tions and robustness and evolvabilty under different b-lactam se-
lection regimes are related to the functional and adaptive archi-
tecture of TEM-1 described by the global saturation
mutagenesis data presented here.
The key property underlying both robustness and evolvability
of TEM-1 is the high activity of the enzyme in vivo—the enzyme
sits far along the saturated region in the activity-fitness relation-
ship (Figure 4). In much the same way that an excess of
thermodynamic stability has been associated with enhanced
protein robustness and evolvability (Bloom et al., 2006; Bloom
et al., 2005; Tokuriki and Tawfik, 2009), our results here make
the more general point that an excess of activity in vivo (from
high catalytic activity or in vivo enzyme concentration, or both)
may underlie both of these properties.
Importantly, these findings suggest new testable hypotheses
for how enzymes like TEM-1 could be selected to have such
high enzymatic activity. TEM-1 is an example of a so-called per-
fect enzyme, catalyzing the hydrolysis of penicillin-class antibi-
otics near the diffusion-controlled limit (Matagne et al., 1998).
Why should it be so highly active if organismal fitness can satu-
rate at much lower levels of activity? One obvious hypothesis is
simply that TEM-1 may have evolved a high activity phenotype
because of direct selection under periods of high concentrations
of penicillin class b-lactam compounds (e.g., ampicillin) or under
conditions of highmutation rate (Wilke et al., 2001). However, the
finding that cefotaxime resistance in TEM-1 predominantly
emerges from mutations that are neutral under ampicillin selec-
tion at low to moderate doses suggests that high activity could
also result indirectly due to selection for evolvability. In this sce-
nario, ancestral TEM-1 also randomly encountered other non-
optimal b-lactams (e.g., cephalosporins). Such conditions would
favor evolvable variants, those bymutation capable of conferring
resistance to non-optimal b-lactams while still maintaining high
fitness in the presence of ampicillin. Given that the data show
that high in vivo enzyme activity underlies robustness, and
robustness in turn promotes new activities through harboring
conditionally neutral mutations, it thus follows that an enzyme
with high activity would be evolutionarily favored under fluctua-
tions in the distribution of b-lactam substrates. Thus, mecha-
nisms that promote evolvability could be selected as a result of
their success under historical environmental fluctuations (Kirsch-
ner and Gerhart, 1998, 2005). Future work will experimentally
address the notion that the history of environmental fluctuations
fundamentally defines the robustness and evolvability of natural
proteins.
EXPERIMENTAL PROCEDURES
Whole-Gene Saturation Mutagenesis Library Construction
A comprehensive whole-gene saturation mutagenesis library was constructed
by an overlap extension PCR mutagenesis technique (Higuchi et al., 1988;
McLaughlin et al., 2012). To permit full coverage of the blaTEM-1 coding region
(789 bp) with 80 base paired-end reads by Illumina sequencing, we split the
sequence into ten subgroups (amino acid positions 26–51, 52–78, 79–104,
105–132, 133–156, 157–183, 184–209, 210–236, 237–264, and 265–290).
The mutagenesis PCR products for the positions of each subgroup were
mixed in equimolar ratios and ligated as a single library. Each subgroup was
independently subject to selection in antibiotic and sample preparation for
Illumina sequencing. A detailed description of the cloning procedure is pro-
vided in the Extended Experimental Procedures.
Antibiotic Selection
All selection experiments for the whole-gene saturation mutagenesis library
were performed in E. coli MegaX DH10B T1 (Invitrogen). Selection was per-
formed in 96-well deep-well plate format at 37C in Luria-Bertani broth (Fisher
Scientific) containing 12 mg/ml tetracycline hydrochloride (Sigma). Wells con-
tained either 0, 10, 39, 156, 625, or 2,500 mg/ml of ampicillin or 0.15 mg/ml ce-
fotaxime at 25-fold concentration. The duration of growth (2 hr) was chosen
to obtain significant selection while maintaining sufficient population size(106 cells) relative to the library diversity and avoiding stationary growth. De-
tails are provided in the Extended Experimental Procedures.
Illumina Sequencing
Samples for Illumina sequencing were prepared by PCR from libraries after
antibiotic selection as previously described (McLaughlin et al., 2012). Addition
of adaptor sequences for Illumina sequencing was performed in two rounds:
the first round amplifies the mutated region of TEM-1, adds the annealing
site for the Illumina paired-end sequencing primer, and incorporates a 4 bp
barcode to indicate the concentration of antibiotic. The second round adds
the remainder of the sequencing primer annealing site along with the annealing
site for the Illumina flow cell. Primer sequences are available upon request.
Illumina sequencing and determination of allele counts were performed as pre-
viously described (McLaughlin et al., 2012). Sequencing was performed at the
UT Southwestern Genomics Core on an Illumina Genome Analyzer IIx using a
version 4 paired-end PE-75 flow cell. Sequences from the Illumina base-caller
were imported into CLC Genomics Workbench and trimmed for size and
quality using a cutoff of 0.01 for the modified Mott algorithm. Custom scripts
written in MATLAB were used to count the number of each allele under each
selection condition and to determine relative fitness values. MATLAB scripts
are available upon request.
Mechanistic Model
A detailed description of the model describing relative fitness as a function
of intracellular b-lactamase activity and ampicillin concentration is provided
in the Extended Experimental Procedures. b-lactam antibiotics inhibit bacterial
growth through competitive inhibition of DD-carboxypeptidases and other
PBPs involved in synthesis of the peptidoglycan layer of bacterial cell walls.
In themodel, relative fitness (Fai ) is proportional to the difference in PBP activity
in the presence of mutant versus wild-type TEM-1. PBP activity is described
according to Michaelis-Menten kinetics, modified to include competitive
inhibition by ampicillin. The periplasmic concentration of ampicillin is deter-
mined by the equilibrium between the flux of antibiotic across the outer mem-
brane and its rate of hydrolysis (inactivation) by b-lactamase (Zimmermann
and Rosselet, 1977). We determined values for the free parameters of our
model (total of 9,998 free parameters for 29,849 data points) by fitting the
experimental data obtained for all 4,997 mutations using a Monte Carlo simu-
lated annealing (MCSA) procedure; the model fits the data well with an overall
r2 = 0. 9767.
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